节点文献

双膦酸盐类药物用于肿瘤辅助治疗的临床研究进展

Clinical research progress of bisphosphonates in adjuvant therapy for various tumors

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 何斌蔡雅霜张志刚黄小芬赵勤俭

【Author】 HE Bin;CAI Ya-shuang;ZHANG Zhi-gang;HUANG Xiao-fen;ZHAO Qin-jian;State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics/National Institute of Diagnostics and Vaccine Development in Infectious Diseases,Xiamen University;School of Public Health,Xiamen University;State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics/National Institute of Diagnostics and Vaccine Development in Infectious Diseasesc,Xiamen University;School of Life Sciences,Xiamen University;

【机构】 厦门大学分子疫苗学与分子诊断学国家重点实验室/国家传染病诊断试剂与疫苗工程技术研究中心厦门大学公共卫生学院厦门大学生命科学学院

【摘要】 双膦酸盐是用于骨骼疾病及钙代谢性疾病治疗的一类药物,主要用于治疗骨质疏松症、佩吉特病、高钙血症等。同时临床研究显示双膦酸盐还可用于多发性骨髓瘤、乳腺癌、肾癌、前列腺癌等疾病的辅助治疗,改善患者的临床结局,尤其是唑来膦酸盐的抗肿瘤效果更具优势,被广泛应用于多种恶性肿瘤的临床研究。本文就双膦酸盐在肿瘤辅助治疗中的临床研究进展进行综述。

【Abstract】 Bisphosphonates are a class of drugs in the treatment of bone diseases and calcium metabolic diseases, and mainly indicated for osteoporosis, Paget’s disease, hypercalcemia, and so on. At the same time,clinical studies have shown that bisphosphonates can be used for the adjuvant treatment of multiple myeloma,breast cancer, kidney cancer, prostate cancer and other diseases and improve the clinical outcome of patients.Particularly, the anti-tumor effect of zoledronic acid is more advantageous. Zoledronic acid has been widely used in the clinical research of various malignant tumors. The clinical research progress of bisphosphonates in adjuvant therapy was reviewed in this paper.

【基金】 国家自然科学基金面上项目(31670939)
  • 【文献出处】 中国新药与临床杂志 ,Chinese Journal of New Drugs and Clinical Remedies , 编辑部邮箱 ,2018年04期
  • 【分类号】R730.5
  • 【被引频次】7
  • 【下载频次】364
节点文献中: 

本文链接的文献网络图示:

本文的引文网络